Literature DB >> 20132208

Ligand binding assays at equilibrium: validation and interpretation.

Edward C Hulme1, Mike A Trevethick.   

Abstract

The focus of this review paper is factors affecting data interpretation in ligand binding assays under equilibrium conditions. Protocols for determining K(d) (the equilibrium dissociation constant) and K(dA) (the equilibrium inhibitor constant) for receptor ligands are discussed. The basic theory describing the interaction of a radiotracer and an unlabelled competitor ligand with a receptor is developed. Inappropriate experimental design may result in ligand depletion and non-attainment of equilibrium, distorting the calculation of K(d) and K(dA) . Strategies, both theoretical and practical, will be given to avoid and correct such errors, thus leading to the determination of reliable values for these constants. In determining K(dA) from competition binding studies, two additional concepts are discussed. First, the necessity to measure an adequate specific binding signal from the bound radiotracer ligand limits the range of affinity constants that can be measured: a particular set of assay conditions may lead to an upper limit on the apparent affinity of unlabelled ligands. Second, an extension of the basic assay methodology can indicate whether the interaction between the tracer and a test ligand is mediated by a competitive or an allosteric mechanism. Finally, the review ends with a discussion of two factors that are often overlooked: buffer composition and the temperature at which the assay is conducted, and the impact these can have on affinity measurements and the understanding of drug interactions.
© 2010 The Authors. Journal compilation © 2010 The British Pharmacological Society.

Mesh:

Substances:

Year:  2010        PMID: 20132208      PMCID: PMC3000649          DOI: 10.1111/j.1476-5381.2009.00604.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Effects of contamination on radioligand binding parameters.

Authors:  S Lazareno; N J Birdsall
Journal:  Trends Pharmacol Sci       Date:  2000-02       Impact factor: 14.819

2.  Binding thermodynamics at the human A(3) adenosine receptor.

Authors:  Stefania Merighi; Katia Varani; Stefania Gessi; Karl Norbert Klotz; Edward Leung; Pier Giovanni Baraldi; Pier Andrea Borea
Journal:  Biochem Pharmacol       Date:  2002-01-15       Impact factor: 5.858

3.  Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  Competitive binding studies with multiple sites. Effects arising from depletion of the free radioligand.

Authors:  J W Wells; N J Birdsall; A S Burgen; E C Hulme
Journal:  Biochim Biophys Acta       Date:  1980-10-15

6.  The effects of ions on the binding of agonists and antagonists to muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; E C Hulme; J W Wells
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

7.  Apparent capacity of cardiac muscarinic receptors for different radiolabeled antagonists.

Authors:  C S Sum; N Pyo; J W Wells
Journal:  Biochem Pharmacol       Date:  2001-10-01       Impact factor: 5.858

8.  Effects of partial agonists and Mg2+ ions on the interaction of M2 muscarinic acetylcholine receptor and G protein Galpha i1 subunit in the M2-Galpha i1 fusion protein.

Authors:  Qingli Zhang; Michiko Okamura; Zeng-Dong Guo; Shunsuke Niwa; Tatsuya Haga
Journal:  J Biochem       Date:  2004-05       Impact factor: 3.387

9.  Affinities of the protonated and non-protonated forms of hyoscine and hyoscine N-oxide for muscarinic receptors of the guinea-pig ileum and a comparison of their size in solution with that of atropine.

Authors:  R B Barlow; E A Winter
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

10.  Modification of the binding properties of muscarinic receptors by gallamine.

Authors:  J M Stockton; N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

View more
  169 in total

1.  BJP issue on drug discovery.

Authors:  Steven J Charlton; Richard A Bond
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 2.  On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Authors:  Georges Vauquelin; Isabelle Van Liefde; David C Swinney
Journal:  Br J Pharmacol       Date:  2016-03-15       Impact factor: 8.739

3.  Protein purification-free method of binding affinity determination by microscale thermophoresis.

Authors:  Lyuba Khavrutskii; Joanna Yeh; Olga Timofeeva; Sergey G Tarasov; Samuel Pritt; Karen Stefanisko; Nadya Tarasova
Journal:  J Vis Exp       Date:  2013-08-15       Impact factor: 1.355

4.  ADP-dependent conformational changes distinguish Mycobacterium tuberculosis SecA2 from SecA1.

Authors:  Nadia G D'Lima; Carolyn M Teschke
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

5.  Synthesis and Preclinical Characterization of a Cationic Iodinated Imaging Contrast Agent (CA4+) and Its Use for Quantitative Computed Tomography of Ex Vivo Human Hip Cartilage.

Authors:  Rachel C Stewart; Amit N Patwa; Hrvoje Lusic; Jonathan D Freedman; Michel Wathier; Brian D Snyder; Ali Guermazi; Mark W Grinstaff
Journal:  J Med Chem       Date:  2017-06-27       Impact factor: 7.446

6.  Concanavalin A-polysaccharides binding affinity analysis using a quartz crystal microbalance.

Authors:  Fohona S Coulibaly; Bi-Botti C Youan
Journal:  Biosens Bioelectron       Date:  2014-03-31       Impact factor: 10.618

7.  The Functional Amyloid Orb2A Binds to Lipid Membranes.

Authors:  Maria A Soria; Silvia A Cervantes; Thalia H Bajakian; Ansgar B Siemer
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

8.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

Review 9.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

10.  Disrupting Fluorescence by Mutagenesis in a Green Fluorescent Fatty Acid Binding Protein from a Marine Eel.

Authors:  Sara Rose Krivoshik; Andrew M Guarnaccia; Daniel B Fried; David F Gruber; Jean P Gaffney
Journal:  Protein J       Date:  2020-04       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.